10K genomes project explores contribution of rare variants to human disease and risk factors
Landmark study confirms complexity and informs the next stages of research
(Press-News.org) The largest population genome sequencing effort to date is published today in Nature. A series of papers describing resources and application of the data is published at the same time in Nature, Nature Genetics, Bioinformatics and Nature Communications.
Rare genetic variants are changes in DNA that are carried only by relatively few people in a population. The UK10K study was designed to explore the contribution of these rare genetic variants to human disease and its risk factors.
"The project has made important new contributions towards describing the role of rare genetic variants in a broad range of disease scenarios and human traits." says Dr Nicole Soranzo, corresponding author from the Wellcome Trust Sanger Institute. "It has shown that the value of sequencing a few thousand individuals is high for highly penetrant, rare diseases, but that for complex traits and diseases much larger sample sizes will be required in future studies. The data and results produced by this project will be instrumental for these future efforts."
The project studied nearly 10,000 individuals, both healthy and affected by disease. The conditions included very rare disorders inherited in families, and more common diseases such as autism, schizophrenia and obesity. In healthy people, 64 different biomedical risk factors such as blood pressure or cholesterol levels were studied. By characterising the DNA sequence of these individuals, the project gained insight into the contribution of rare variants to a broad range of disease scenarios, and discovered new genetic variants and genes underpinning disease risk.
"The UK10K project has increased the resolution of genetic discoveries. It has enabled access to a much denser set of variants within the genome in the UK population, which can be used to refine our understanding of genetic effect on phenotypic traits," explains Richard Durbin, senior UK10K researcher at the Sanger Institute. "In earlier studies either very rare variants with big effects or common variants, which usually only have small effects, could be analysed. Now we have been able to explore an increased part of the spectrum of variation in between the very rare and the common ones."
A series of papers published today in Nature and Nature Genetics in collaboration with other investigators demonstrates the value of these data for genetic discoveries.
As efforts continue to characterise the genetic underpinnings of complex diseases, the data and results of this study are expected to enable the next wave of discoveries. The UK10K sequence reference panel, described in greater detail in a companion paper published in Nature Communications, has been shown to greatly increase the ability to characterise rare variants in large population samples available to the worldwide research community. This resource will enable researchers to 'fill in' missing data from lower resolution genotype studies, allowing them to explore full genotypes more quickly and cheaply.
In addition, the authors have developed a web-based browser of association based on the Dalliance platform, described in a companion paper in Bioinformatics. This genome browser allows the easy retrieval of association results for all disease risk traits analysed in the study. Scientists investigating these specific disease risk factors will be able to directly access the consequence of a person's DNA sequence to see how common any genetic variants they have are and what traits these variations are associated with.
"The UK10K project was an enormous undertaking and has laid the ground for future studies, " says Klaudia Walter, a leading author from the Sanger Institute. "For instance, the benefits of the new UK10K haplotype reference panel are already being realised in analyses of international consortia as well as the 0.5M people UK BioBank study."
Notes to Editors
The UK10K Consortium (2015). The UK10K project identifies rare variants in health and disease. Nature. DOI: http://dx.doi.org/10.1038/nature14962
Zheng H, Forgetta V et al. (2015). Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture. Nature. DOI : http://dx.doi.org/10.1038/nature14878
Huang J, Howie B, et al. (2015). Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel. Nature communications. DOI: http://dx.doi.org/10.1038/ncomms9111
Geihs M, Yan Y, et al. (2015). An interactive genome browser of association results from the UK10K cohorts project. Bioinformatics. DOI: 10.1093/bioinformatics/btv491
The Wellcome Trust provided funding for UK10K (WT091310). Additional grant support and acknowledgements can be found in the paper.
A full list of participants and participating centres can be found in the paper.
The UK10K project will enable researchers in the UK and beyond to better understand the link between low-frequency and rare genetic changes, and human disease caused by harmful changes to the proteins the body makes.
The Wellcome Trust Sanger Institute is one of the world's leading genome centres. Through its ability to conduct research at scale, it is able to engage in bold and long-term exploratory projects that are designed to influence and empower medical science globally. Institute research findings, generated through its own research programmes and through its leading role in international consortia, are being used to develop new diagnostics and treatments for human disease.
The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. We support the brightest minds in biomedical research and the medical humanities. Our breadth of support includes public engagement, education and the application of research to improve health. We are independent of both political and commercial interests.
ELSE PRESS RELEASES FROM THIS DATE:
This news release is available in Spanish.
Final OS and subgroup analysis of the pivotal study SAR-3007
First interim results of the Y-IMAGE prospective study showing real-world data for trabectedin in advanced soft tissue sarcoma (STS)
Clinical data of trabectedin in translocated-related sarcomas, and in advanced leiomyosarcomas and liposarcomas
Early clinical studies of PM1183 in combination with paclitaxel or cisplatin show a synergistic activity
Madrid, September 14, 2015: PharmaMar announces that it will show new data from clinical pivotal ...
This news release is available in French. We have known for some years that Alzheimer's disease is characterised by two types of lesions, amyloid plaques and degenerated tau protein. Cholesterol plays an important role in the physiopathology of this disease. Two French research teams (Inserm/CEA/University of Lille/University of Paris-Sud ) have just shown, in a rodent model, that overexpressing an enzyme that can eliminate excess cholesterol from the brain may have a beneficial action on the tau component of the disease, and completely correct it. This is the first ...
WASHINGTON, Sept. 14, 2015 -- It's a condition that turns the lives of millions of Americans upside-down: addiction. Whether it's alcohol, drugs, food or gambling, it can ruin lives. In support of National Recovery Month, which calls attention to substance abuse issues and treatment services, Reactions takes a look at the chemistry behind addiction. Check it out here: https://youtu.be/C6I3CHhBGeQ.
Subscribe to the series at http://bit.ly/ACSReactions, and follow us on Twitter @ACSreactions to be the first to see our latest videos.
INFORMATION:The American Chemical ...
DURHAM, N.C. -- Protected areas not only keep significant swaths of Indonesia's shrinking mangrove habitats intact, but also prevent emissions of carbon dioxide that would have been released had these mangroves been cleared, according to a study in the journal Ecological Economics.
Published online, the analysis examined the success of protected areas between 2000 and 2010, finding that their use has avoided the loss of 14,000 hectares of mangrove habitat.
"This is not a small number," said Daniela Miteva, a postdoctoral researcher at The Nature Conservancy and a Duke ...
Whether you have taken a side or a backseat in the discussion, the "food versus fuel" debate affects us all. Some say growing more biofuel crops today will decrease greenhouse gas emissions, but will make it harder to produce food tomorrow, which has prevented the U.S. from maximizing the potential of environmentally beneficial biofuels.
In a recent article, published by the National Academy of Engineering, University of Illinois' Gutgsell Endowed Chair of Plant Biology and Crop Sciences Steve Long and University of California's Philomathia Professor of Alternative Energy ...
University of Queensland scientists have found a genetic basis for height and body mass differences between European populations.
Queensland Brain Institute researcher Dr Matthew Robinson said the findings could explain why people from northern European countries tended on average to be taller and slimmer than other Europeans.
He said the genes that resulted in greater height correlated strongly with genes that reduced body mass index.
"Our findings give a genetic basis to the stereotype of Scandinavians as being tall and lean," Dr Robinson said.
The study paves ...
Researchers at the Johns Hopkins University have found molecular evidence of how a biochemical process controls the lengths of protective chromosome tips, a potentially significant step in ultimately understanding cancer growth and aging.
In a paper recently published as the cover story in the online journal eLife, biologist David C. Zappulla and graduate student Evan P. Hass show how in baker's yeast cells, two proteins work together to usher a key enzyme to the chromosome tip, the telomere, to restore its length, which diminishes with each round of cell division.
A new study from researchers at Uppsala University shows that variation in genome size may be much more important than previously believed. It is clear that, at least sometimes, a large genome is a good genome.
'Our study shows that females with larger genome lay more eggs and males with larger genome fertilize more eggs', says research leader Göran Arnqvist, Professor of Animal Ecology at Uppsala University.
The study of seed beetles is published in the scientific journal Proceedings of the Royal Society of London.
The amount of nuclear DNA per cell, or the ...
Philadelphia, PA, September 14, 2015 - One in four middle-aged adults who survive to age 85 will develop heart failure, according to current estimates. Intervention programs to improve lifestyles are widely advocated, but do they actually work? Investigators in the U.S. and Taiwan independently examined programs that may reduce cardiovascular risk and concluded that both programs will reduce lifetime risk of heart failure. Results are reported in The American Journal of Medicine.
A group of American investigators estimated whether greater adherence to the American Heart ...
Philadelphia, PA, September 14, 2015 - The latest issue of Biological Psychiatry presents the results of three studies implicating metabotropic glutamate receptor 2 (mGluR2) as a new molecular target for the treatment of addiction.
Group II metabotropic glutamate receptors, which include the subtypes mGluR2 and mGluR3, have been known targets for addiction treatment. Unfortunately, mGluR2/3 agonists studied to date have shown important limitations, including development of tolerance and decreasing food intake along with drug intake. Thus, scientists have been working ...
LAST 30 PRESS RELEASES: